The Head and Neck Cancer is a cluster
of cancers that are initiated in the mouth cavity, oral cavity, salivary
glands, lip, larynx, pharynx, nasal, and paranasal sinuses. It has been marked
that maximum rates of Head & Neck Cancer arise from the squamous cell
carcinomas in the epithelium of the various parts of head and neck. The Head
& Neck Cancer comprises various symptoms that include difficulty in swallowing,
change in voice, a sore in throat that persists, bleeding from mouth, weight
loss, ulcers, unusual breathing, formations of lumps in the mouth or lips, etc.
There are various risk factors
that are associated with Head & Neck Cancer such as excessive alcohol
intake, tobacco consumption, infection from Human papillomavirus, exposure to
high dosages of radiation therapy, and so on. The factors that propel the
growth of the global Head & Neck Cancer Market include mounting geriatric
population, increasing incidences of Head & Neck Cancer all over the globe,
disposable income, and government initiatives for sophisticated healthcare
aspects.
View Summary of This Report @ https://www.millioninsights.com/industry-reports/head-neck-cancer-treatment-market
On the other hand, there are
also factors that hinder the growth of Head & Neck Cancer Market including
patent expiry of current drugs, side effects post treatment, difficulty in
diagnosis, and the high expenditure on the cancer therapy. The global Head
& Neck Cancer Market has been classified on the basis of type, stages, diagnostic
method, treatment, end–user, and geography. On the basis of type, the global
Head & Neck Cancer Market size constitutes nasal cavity and paranasal sinus
cancer, nasopharyngeal cancer, laryngeal and hypo pharyngeal cancer, oral and
oropharyngeal cancer, and salivary gland cancer. During the forecast period
oral cancer is expected to account for the largest share in the global Head
& Neck Cancer Market.
On the basis of Head &
Neck Cancer stage, the global Head & Neck Cancer Market size comprises
stage 0, stage I, stage II, stage III, and stage IV. Cancer staging is an
important aspect as it guides the doctors to categorize the approach of
treatment and also to conclude the spread of cancer.
On the basis of diagnostic
method, the global Head & Neck Cancer Market size constitutes bioscopy
screening tests, blood tests, dental diagnostic method, imaging diagnostic
equipment, and endoscopy screening equipment. The imaging diagnostic equipment
sector can be further classified as MRI, X-rays, CT scan, ultrasound, and PET.
On the basis of treatment, the global Head & Neck Cancer Market size covers
surgery, chemotherapy, radiation therapy, external radiation therapy, internal
radiation therapy, and targeted therapy. During the forecast period surgery is
estimated to dominate the treatment sector. Radiation therapy is followed by
surgery owing to its utility in inhibition and reappearance of cancer.
Request a Sample
Copy of This Report @ https://www.millioninsights.com/industry-reports/head-neck-cancer-treatment-market/request-sample
No comments:
Post a Comment